Navigation Links
Neuland Labs Reports Financial Results For Fiscal Year 2012
Date:5/3/2012

HYDERABAD, India, May 3, 2012 /PRNewswire/ -- Neuland Laboratories Ltd., (NSE:NEULANDLAB; BOM:524558) a pharmaceutical manufacturer providing active pharmaceutical ingredients (APIs), complex intermediates, and contract research and manufacturing services to customers located in 85 countries, today announced financial results for the 2012 fiscal year (FY) ended March 31, 2012.

"We are pleased to begin the new fiscal year with the successful closing of our rights offering, which has both strengthened the firm's equity and infused cash into operations to fuel growth.  We continue to see promise in all three Neuland business segments -- APIs, Contract Research and Manufacturing and Peptides, and we look forward to continued growth during the coming year," said Dr. D.R. Rao, Chairman and Managing Director of Neuland Labs. 

Revenues for FY 2012 were $88.07 million (4.48 billion INR*) compared to FY 2011 revenues of $78.04 million (3.97 billion INR*), an increase of 13%.  The increase in revenues primarily reflects gains in sales of the company's products and services from its API and Contract Research and Manufacturing businesses.

Neuland reported FY 2012 EBITDA of $9.50 million (483 million INR*), compared to EBITDA of $9.83 million (500 million INR*) in FY 2011.  The decrease in EBITDA primarily reflected higher costs for raw materials, energy and other inputs during the 2012 fiscal year.

After-tax profits in FY 2012 were $0.40 million (20 million INR*), compared to after-tax profits in FY 2011 of $1.00 million (51 million INR*).  The decrease in after-tax profits primarily reflects increases infinance costs and the impact of foreign exchange adjustments.

"We launched four new APIs for the generic market in the past year, which have all been successful in terms of our customers' ability to gain significant market share based on the strong pricing position and sustainable capacity our products make possib
'/>"/>

SOURCE Neuland Laboratories Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Neuland Labs Reports First Quarter Fiscal Year 2012 Financial Results
2. Neuland Labs Launches Expanded Peptide Manufacturing Capabilities at 22nd American Peptide Symposium
3. Neuland Labs Reports Financial Results for Fiscal Year 2011
4. Valeant Pharmaceuticals Reports 2012 First Quarter Financial Results
5. GP Strategies Reports Strong First Quarter 2012 EPS of $0.23
6. Cardinal Health Reports Third-Quarter Results
7. Lexicon Pharmaceuticals Reports On Clinical Program Status And 2012 First Quarter Results
8. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
9. Neurocrine Biosciences Reports First Quarter 2012 Results
10. CVS Caremark Reports Record First Quarter Results
11. National Study: Teen "Heavy" Marijuana Use Up 80 Percent Since 2008, One in Ten Teens Reports Using Marijuana at Least 20 Times a Month
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... TAMPA, Fla. , May 22, 2015 /PRNewswire-USNewswire/ ... Hospital,s Heart Institute recently traveled to ... Convergent procedure at the 2015 Heart Rhythm Society ... experts together to focus on the ideas, people ... Convergent is a hybrid, minimally invasive ...
(Date:5/22/2015)... 2015 The North American dental lasers ... estimated to reach $90.7 million by 2019, at a CAGR ... the TOC of North America Dental Lasers Market for an ... various tables and figures. http://www.micromarketmonitor.com/market/north-america-dental-lasers-1771208223.html ... report.   Dental lasers are specifically used ...
(Date:5/22/2015)... , May 22, 2015  The U.S. Food ... (filgrastim-sndz) -- the first biosimilar product approved in ... points toward growth in the contract manufacturing organization ... CMO industry is geared to the production of ... major biopharmaceutical products. The healthcare market research publisher,s ...
Breaking Medicine Technology:St. Joseph's Hospital Heart Institute Physician Presents at Heart Rhythm Society 2St. Joseph's Hospital Heart Institute Physician Presents at Heart Rhythm Society 3North America Dental Lasers Market is Expected to Reach $90.7 Million by 2019, at a CAGR of 9.2% From 2014 to 2019 2North America Dental Lasers Market is Expected to Reach $90.7 Million by 2019, at a CAGR of 9.2% From 2014 to 2019 3Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 2Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 3Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 4
... , KRX-0401 + Capecitabine More Than Doubles Time ... Overall Survival vs. Capecitabine + Placebo in Patients with ... NEW YORK, June 1 Keryx Biopharmaceuticals, Inc. (Nasdaq: ... of KRX-0401 (perifosine), the Company,s Akt-inhibitor for cancer, in combination ...
... GATESHEAD, England, June 1 A leading GP has ... around the world the hope of combating the killer disease. , ... of Ateronon, the natural supplement,developed by Cambridge scientists, was a huge ... heart attacks and stroke. , Dozens of ...
Cached Medicine Technology:Keryx Biopharmaceuticals Announces Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer 2Keryx Biopharmaceuticals Announces Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer 3Keryx Biopharmaceuticals Announces Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer 4Keryx Biopharmaceuticals Announces Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer 5Keryx Biopharmaceuticals Announces Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer 6Heart Disease Treatment Breakthrough 2Heart Disease Treatment Breakthrough 3
(Date:5/22/2015)... San Francisco, CA (PRWEB) May 22, 2015 ... is hosting two exciting events in June. They will ... First Professional Doctorate and a two-day class on Classical ... 1:30-2:30 p.m. June 3, Dr. Steve Given, the Dean ... he will discuss the new First Professional Doctorate program. ...
(Date:5/22/2015)... Omar Ahmad Barrada, a junior at Milton Hershey ... Congress of Future Medical Leaders in Boston, Mass. The ... highest achieving high school students.” , “I’m excited to ... and learn better study habits,” said Omar. “The event ... can ask the surgeons questions.” , The goal is ...
(Date:5/22/2015)... May 22, 2015 Carnegie Science ... today announced a new partnership to develop BodyTech, a ... region. The initiative includes a new exhibit at the ... demonstration theater, and a new traveling science show, Anatomy ... of 2015. , Designed to explore a wide ...
(Date:5/22/2015)... MOUNTAIN VIEW, California (PRWEB) May 22, 2015 ... Breakers, has set a RecordSetter.com World Record at the 104th ... Coco Libre coconut water ice luge served 315 people in ... Zappos.com Bay to Breakers race is so true to the ... that we felt bringing an ice luge to the finish ...
(Date:5/22/2015)... New York, NY (PRWEB) May 22, 2015 ... abstract entitled “Positivity Rates and Genotype Results in ‘Baby ... Action: Results from a Nationwide Lab Test Database” at Digestive ... conducted by Medivo’s Clinical Affairs and Analytics team members Carol ... Dhaliwal, MD; and Andrea Parker, MSI, along with Nancy Reau, ...
Breaking Medicine News(10 mins):Health News:ACTCM Announces Upcoming June Events 2Health News:Milton Hershey School Student Chosen for Congress of Future Medical Leaders 2Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 2Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 3Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 4Health News:Coco Libre Ice Luge Sets New World Record at Bay to Breakers 2Health News:Medivo Study Finds HCV Positivity Rates are 250% Higher Among Baby Boomers 2
... know answers to everything. This gains special// importance when we ... we questioned the diseases that make our precious body their ... a breakthrough have unraveled the mystery surrounding heart failure. They ... heart uses too much fatty acid and not enough carbohydrate; ...
... findings of a recent study researchers say Cocoa flavonols, ... on the brain. Cocoa flavonols were found to increase blood ... a study on 16 healthy young women, researcher tested the ... were asked to consume a flavonol-rich CocoaVia drink made by ...
... a key gene that controls specialized brain cells// is ... to better treatment of conditions ranging from schizophrenia to ... University of Singapore (NUS) study has unveiled a new ... protective fatty nerve coverings. Named juxtanodin, the gene speeds ...
... with an asthmatic attack// in children can go a long ... from asthma., ,Asthma is a leading cause of death ... is one of the leading causes of hospitalization in school-age ... day in school, experts say it is imperative that everyone ...
... responsible for post-traumatic nightmares according// to a new research. ... recognized condition that results in unpleasant memories that can ... researchers have discovered what causes this following experiments on ... event are remembered longer by a person than a ...
... hearing loss in people apart// from the all other ... The researches are featured in the July edition of ... researchers have found a previously unreported hereditary syndrome composed ... due to a lesion of the auditory division of ...
Cached Medicine News:Health News:Knowledge Of Asthma For Teachers Can Help Children 2Health News:Research Finds How Post-traumatic Stress Leads to Long-Lasting Memories 2Health News:Research Finds How Post-traumatic Stress Leads to Long-Lasting Memories 3Health News:Studies On Hearing Loss Discovers New Causes 2
... the essence of what Siemens represents: innovative ... compact size that offers enhanced solutions that ... and cost-conscious investor. Available in 2-slice, ... able to perform routine and advanced applications ...
... highly respected single-source CT solution, from imaging ... With its proprietary STRATON X-ray tube, Siemens ... 0.33s, virtually freezing the hearts motion. Utilizing ... unprecedented diagnostic detail with up to 64 ...
... Bravo is a SmartBeam platform providing high-performance scanning ... two most vital clinical sites - spine and ... dose., ,The full-function DPX Bravo densitometer gives you ... footprint. You can place it in almost any ...
... Pachmate (DGH 55) is the ultimate in portable ... ounces in weight. The Pachmate is a handheld ... The Pachmate will easily fit in a ... is rugged in design and one of the ...
Medicine Products: